Phase II Study of Vinorelbine in the Treatment of Platinum-Resistant Ovarian Carcinoma
- 30 April 2001
- journal article
- clinical trial
- Published by Elsevier in Gynecologic Oncology
- Vol. 81 (1) , 58-62
- https://doi.org/10.1006/gyno.2000.6089
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Ifosfamide and vinorelbine in advanced pretreated ovarian cancer: a phase II studyCancer Chemotherapy and Pharmacology, 2000
- Phase II Trial of Vinorelbine in Recurrent and Progressive Epithelial Ovarian CancerGynecologic Oncology, 1999
- A Phase I Study of a Daily ×3 Schedule of Intravenous Vinorelbine for Refractory Epithelial Ovarian CancerGynecologic Oncology, 1998
- Phase II study of vinorelbine in patients with pretreated advanced ovarian cancer: activity in platinum-resistant disease.Journal of Clinical Oncology, 1996
- Long-term follow-up of patients with advanced ovarian carcinoma treated with chemotherapyAnnals of Oncology, 1993
- A Prospective Randomized Comparison of 6 and 12 Cycles of Cyclophosphamide, Adriamycin, and Cisplatin in Advanced Epithelial Ovarian Cancer: A Danish Ovarian Study Group Trial (DACOVA)Gynecologic Oncology, 1993
- Second‐line chemotherapy for recurrent carcinoma of the ovaryCancer, 1993
- Carboplatin and cyclophosphamide salvage therapy for ovarian cancer patients relapsing after cisplatin combination chemotherapyEuropean Journal of Cancer and Clinical Oncology, 1991
- Salvage chemotherapy for ovarian cancer recurrence: Weekly cisplatin in combination with epirubicin or etoposideGynecologic Oncology, 1991
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958